Matt Angle
Neuroscientist with a Ph.D. in Neuroscience from the University of Heidelberg and postdoctoral research at Stanford University's Department of Materials Science and Engineering, where he pioneered next-generation electronics for large-scale, high-fidelity neural recording. He founded Paradromics in 2015 in Austin, Texas, securing competitive NIH and DARPA contracts to develop a high-data-rate BCI designed to restore speech communication for people with severe motor impairments. The company's Connexus system holds two FDA Breakthrough Device Designations and achieved its first-in-human neural recording in May 2025, with reported information transfer rates exceeding 200 bits per second.
